secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2026-01-30T23:59:59+00:00
Accession:  0001213900-26-009792
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics implements 1-for-4 reverse stock split effective Jan 29, 2026
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-4 ratio; outstanding shares reduced from ~2,834,133 to ~708,533.
- Shares from prefunded warrants reduced from 1,055,000 to 263,750; no fractional shares issued.
- Common stock continues trading under symbol 'BJDX' on Nasdaq; new CUSIP 095633608.
- Board approved final ratio on Jan 27, 2026; Certificate of Amendment filed with Delaware.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390026009792/0001213900-26-009792-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390026009792/ea0274800-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-009792

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer